HIGH RESISTANCE IMPLANTED BRONCHIAL ISOLATION DEVICES AND METHODS

    公开(公告)号:US20240156584A1

    公开(公告)日:2024-05-16

    申请号:US18511782

    申请日:2023-11-16

    IPC分类号: A61F2/04 A61M16/20

    摘要: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at higher than normal breathing pressures.

    High resistance implanted bronchial isolation devices and methods

    公开(公告)号:US11857406B2

    公开(公告)日:2024-01-02

    申请号:US18055729

    申请日:2022-11-15

    IPC分类号: A61F2/04 A61M16/20

    摘要: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at higher than normal breathing pressures.

    High resistance implanted bronchial isolation devices and methods

    公开(公告)号:US10758333B2

    公开(公告)日:2020-09-01

    申请号:US15714868

    申请日:2017-09-25

    摘要: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at coughing pressures.

    Systems and methods for flushing an assessment catheter

    公开(公告)号:US10478125B2

    公开(公告)日:2019-11-19

    申请号:US14195532

    申请日:2014-03-03

    发明人: Lutz Freitag

    IPC分类号: A61B5/00 A61B5/08

    摘要: Devices systems and methods are disclosed for removing secretions from the lumen of a functional assessment catheter for the lungs. The system comprises a flushing unit configured to deliver a clearing fluid to the lumen of the pulmonary catheter to remove debris, secretions, or moisture from the lumen or sensors.

    Collateral flow channel sealant delivery methods and systems

    公开(公告)号:US10413300B2

    公开(公告)日:2019-09-17

    申请号:US15182453

    申请日:2016-06-14

    摘要: Devices, methods, and systems are provided for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment. A video-assisted thoracoscopic device is inserted into a thoracic cavity of a patient and positioned at a fissure between a target lung compartment and an adjacent lung compartment. A collateral flow channel between the target lung compartment and the adjacent lung compartment is then identified using the video-assisted thoracoscopic device and an agent is injected into the collateral flow channel, thereby reducing the collateral flow channel.